Use of sodium-glucose co-transporter 2 inhibitors and risk of serious #renal events: Scandinavian cohort study
..Cohort of 29โ887 new users of SGLT2 inhibitors (follow-up time: dapagliflozin 66.1%; empagliflozin 32.6%; canagliflozin 1.3%) and 29โ887 new users of an active comparator, dipeptidyl peptidase-4 inhibitors, matched 1:1 on the basis of a propensity score with 57 variables. Mean follow-up time was 1.7 (SD 1.0) years. ..The mean age of the study population was 61.3 (SD 10.5) years; 11โ108 (19%) had cardiovascular disease, and … Continue reading Use of sodium-glucose co-transporter 2 inhibitors and risk of serious #renal events: Scandinavian cohort study